1. Home
  2. TLYS vs TLSA Comparison

TLYS vs TLSA Comparison

Compare TLYS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$4.20

Market Cap

128.1M

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.00

Market Cap

124.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
TLSA
Founded
1982
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.1M
124.0M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
TLYS
TLSA
Price
$4.20
$1.00
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
134.9K
534.3K
Earning Date
06-03-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
62.34
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.66
N/A
Revenue Next Year
$1.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$0.87
52 Week High
$5.90
$2.53

Technical Indicators

Market Signals
Indicator
TLYS
TLSA
Relative Strength Index (RSI) 52.16 42.55
Support Level $3.60 $0.87
Resistance Level $4.59 $1.45
Average True Range (ATR) 0.22 0.12
MACD 0.06 0.01
Stochastic Oscillator 72.15 38.07

Price Performance

Historical Comparison
TLYS
TLSA

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley, among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: